Compare · CBLL vs QTI
CBLL vs QTI
Side-by-side comparison of CeriBell Inc. (CBLL) and QT Imaging Holdings Inc. (QTI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBLL and QTI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CBLL is the larger of the two at $1.02B, about 36.8x QTI ($27.6M).
- CBLL has been more active in the news (9 items in the past 4 weeks vs 8 for QTI).
- CBLL has more recent analyst coverage (8 ratings vs 0 for QTI).
- Company
- CeriBell Inc.
- QT Imaging Holdings Inc.
- Price
- -
- -
- Market cap
- $1.02B
- $27.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 9
- 8
- Recent ratings
- 8
- 0
Latest CBLL
- Director Burke William W exercised 18,000 shares at a strike of $4.70 and sold $479,480 worth of shares (18,000 units at $26.64) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by CeriBell Inc.
- Director Taylor Joseph Michael sold $277,644 worth of shares (10,200 units at $27.22), decreasing direct ownership by 21% to 38,278 units (SEC Form 4)
- Chief Technology Officer Woo Raymond exercised 4,887 shares at a strike of $3.65 and sold $131,754 worth of shares (4,887 units at $26.96) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by CeriBell Inc.
- CeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ceribell Reports Third Quarter 2026 Financial Results
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Latest QTI
- QT Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by QT Imaging Holdings Inc.
- QT Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone
- QT Imaging Secures First GCC Commercial Order from American Hospital Dubai, Plans Clinical Research Collaboration
- QT Imaging Secures Medicare Outpatient Reimbursement for QTscan®, Effective January 2027
- QT Imaging to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026
- QT Imaging’s Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier
- QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective